A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Description

The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive behavioral therapy. For example, the researchers will see if personal characteristics (like age, sex, race, and education) and ways of thinking (like expectations of therapy) may affect how well participants respond.

Conditions

Survivorship

Talk to us

Study Overview

On this page

Study Details

Study overview

The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive behavioral therapy. For example, the researchers will see if personal characteristics (like age, sex, race, and education) and ways of thinking (like expectations of therapy) may affect how well participants respond.

Music Therapy vs. Cognitive-Behavioral Therapy for Cancer-related Anxiety (MELODY)

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Condition
Survivorship
Intervention / Treatment

-

Contacts and Locations

Miami

Baptist Alliance MCI, Miami, Florida, United States, 33143

New York

Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065

Philadelphia

Drexel University, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English- or Spanish-speaking
  • * 18 years or older
  • * Prior cancer diagnosis of any type or stage
  • * Free of oncological disease, or stable disease with no evidence of progression
  • * Score of ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
  • * Report anxiety symptoms lasting at least one month
  • * Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MT or CBT
  • * Access to Zoom and a quiet/private location
  • * English-speaking
  • * 18 years or older
  • * Advanced cancer diagnosis: stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or leukemia
  • * Currently receiving oncological treatment or on active surveillance
  • * Karnofsky performance score of ≥60
  • * Score of ≥8 on the HADS anxiety subscale
  • * Anxiety symptoms lasting for at least 1 month
  • * Greater than 6-month expected survival as judged by the treating oncologist
  • * Willing to adhere to all study procedures
  • * Access to Zoom and a quiet/private location
  • * Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed).
  • * Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse
  • * Score of ≥10 indicative of cognitive impairment on the Blessed Orientation-Memory-Concentration
  • * Received a treatment course of seven or greater MT or CBT sessions for anxiety symptoms within the last six months
  • * Unable to provide informed consent for themselves
  • * Active suicidal ideation; bipolar disorder, schizophrenia, or substance abuse
  • * Score of ≥10 on Blessed Orientation-Memory-Concentration
  • * Prior receipt of MT within the past six months
  • * Plan to receive any form of psychotherapy in the coming 8 weeks
  • * Initiation or change in anxiety medications within the past 4 weeks
  • * Plan to initiate or change anxiety medications in the coming 8 weeks
  • * Unable to provide informed consent for themselves

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Jun Mao, MD, MSCE, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2025-01